[1]
“Outcome of diffuse large B-cell lymphoma patients treated with different chemotherapeutic regimens (R-DA-EPOCH vs R-CHOP)”, Birdem Med J, vol. 12, no. 3, pp. 188–194, Sep. 2022, doi: 10.3329/birdem.v12i3.61688.